34906 Federal Register / Vol. 63, No. 123 / Friday, June 26, 1998 / Notices

Type of report Number of respondents

Hours per responseTotal burden

hours

Total ...................................................................................................................................... 30 ........................ 3,630

Written comments and

recommendations concerning the

proposed information collection should

be sent within 30 days of this notice to:

Laura Oliven, Human Resources and

Housing Branch, Office of Management

and Budget, New Executive Office

Building, Room 10235, Washington, DC

20503.

Dated: June 19, 1998.

Jane Harrison,

Director, Division of Policy Review and

Coordination.

[FR Doc. 98–17065 Filed 6–25–98; 8:45 am]

BILLING CODE 4160–15–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Health Resources and Services

Administration

National Vaccine Injury Compensation

Program; List of Petitions Received

AGENCY: Health Resources and Services

Administration, HHS.

ACTION: Notice.

SUMMARY: The Health Resources and

Services Administration (HRSA) is

publishing this notice of petitions

received under the National Vaccine

Injury Compensation Program (‘‘the

Program’’), as required by section

2112(b)(2) of the Public Health Service

(PHS) Act, as amended. While the

Secretary of Health and Human Services

is named as the respondent in all

proceedings brought by the filing of

petitions for compensation under the

Program, the United States Court of

Federal Claims is charged by statute

with responsibility for considering and

acting upon the petitions.

FOR FURTHER INFORMATION CONTACT: For

information about requirements for

filing petitions, and the Program

generally, contact the Clerk, United

States Court of Federal Claims, 717

Madison Place, N.W., Washington, D.C.

20005, (202) 219–9657. For information

on HRSA’s role in the Program, contact

the Director, National Vaccine Injury

Compensation Program, 5600 Fishers

Lane, Room 8A35, Rockville, MD 20857,

(301) 443–6593.

SUPPLEMENTARY INFORMATION: The

Program provides a system of no-fault

compensation for certain individuals

who have been injured by specified

childhood vaccines. Subtitle 2 of title

XXI of the PHS Act, 42 U.S.C. 300aa–

10 et seq., provides that those seeking

compensation are to file a petition with

the U.S. Court of Federal Claims and to

serve a copy of the petition on the

Secretary of Health and Human

Services, who is named as the

respondent in each proceeding. The

Secretary has delegated her

responsibility under the Program to

HRSA. The Court is directed by statute

to appoint special masters who take

evidence, conduct hearings as

appropriate, and make initial decisions

as to eligibility for, and amount of,

compensation.

A petition may be filed with respect

to injuries, disabilities, illnesses,

conditions, and deaths resulting from

vaccines described in the Vaccine Injury

Table (the Table) set forth at section

2114 of the PHS Act or as set forth at

42 CFR 100.3, as applicable. This Table

lists for each covered childhood vaccine

the conditions which will lead to

compensation and, for each condition,

the time period for occurrence of the

first symptom or manifestation of onset

or of significant aggravation after

vaccine administration. Compensation

may also be awarded for conditions not

listed in the Table and for conditions

that are manifested after the time

periods specified in the Table, but only

if the petitioner shows that the

condition was caused by one of the

listed vaccines.

Section 2112(b)(2) of the PHS Act, 42

U.S.C. 300aa–12(b)(2), requires that the

Secretary publish in the Federal

Register a notice of each petition filed.

Set forth below is a list of petitions

received by HRSA on January 5, 1998,

through March 31, 1998.

Section 2112(b)(2) also provides that

the special master ‘‘shall afford all

interested persons an opportunity to

submit relevant, written information’’

relating to the following:

1. The existence of evidence ‘‘that

there is not a preponderance of the

evidence that the illness, disability,

injury, condition, or death described in

the petition is due to factors unrelated

to the administration of the vaccine

described in the petition,’’ and

2. Any allegation in a petition that the

petitioner either:

(a) ‘‘Sustained, or had significantly

aggravated, any illness, disability,

injury, or condition not set forth in the

Table but which was caused by’’ one of

the vaccines referred to in the Table, or

(b) ‘‘Sustained, or had significantly

aggravated, any illness, disability,

injury, or condition set forth in the

Table the first symptom or

manifestation of the onset or significant

aggravation of which did not occur

within the time period set forth in the

Table but which was caused by a

vaccine’’ referred to in the Table.

This notice will also serve as the

special master’s invitation to all

interested persons to submit written

information relevant to the issues

described above in the case of the

petitions listed below. Any person

choosing to do so should file an original

and three (3) copies of the information

with the Clerk of the U.S. Court of

Federal Claims at the address listed

above (under the heading FOR FURTHER

INFORMATION CONTACT), with a copy to

HRSA addressed to Acting Associate

Administrator for Health Professions,

5600 Fishers Lane, Room 8–05,

Rockville, MD 20857. The Court’s

caption (Petitioner’s Name v. Secretary

of Health and Human Services) and the

docket number assigned to the petition

should be used as the caption for the

written submission.

Chapter 35 of title 44, United States

Code, related to paperwork reduction,

does not apply to information required

for purposes of carrying out the

Program.

List of Petitions

1. Stephanie and John Hatzenbuhler, on

behalf of John Ross Hatzenbuhler

Bismark, North Dakota, Court of

Federal Claims Number 98–0008V

2. Basmah Zamrik and Mohammad

Ramez Chawki on behalf of Hedaya

Chawki, Broken Arrow, Oklahoma,

Court of Federal Claims Number 98–

0010V

3. Dennis Foster on behalf of Felisha

Foster, Rockford, IIlinois, Court of

Federal Claims Number 98–0033V

4. Dolores Cohen-Lowry, Phoenixville,

Pennsylvania, Court of Federal Claims

Number 98–0034V

5. Pamela S. and Andrew L. Wilson on

behalf of Daniel J. Wilson, Beaver,

Pennsylvania, Court of Federal Claims

Number 98–0040V

6. Christine E. Kramer, Mayfield

Heights, Ohio, Court of Federal

Claims Number 98–0053V

7. Thuy Yang on behalf of Chandra Ly,

Deceased, Philadelphia,

Pennsylvania, Court of Federal Claims

Number 98–0054V
Federal Register / Vol. 63, No. 123 / Friday, June 26, 1998 / Notices 34907

8. Susan and Leonard Queen on behalf

of Maura Queen, Douglasville,

Georgia, Court of Federal Claims

Number 98–0055V

9. Vanya Seiss on behalf of Lola Seiss,

Los Angeles, California, Court of

Federal Claims Number 98–0062V

10. Rosemary J. Browne, Columbia,

Maryland, Court of Federal Claims

Number 98–0070V

11. Cathleen and Donald Marcelli on

behalf of David Marcelli, Deceased,

Burlington, Massachusetts, Court of

Federal Claims Number 98–0103V

12. Eva D. Libby Smith on behalf of

Aaron Lee Smith, Portsmouth,

Oregon, Court of Federal Claims

Number 98–0106V

13. UnMi and Jerry Tufo on behalf of

Jerry Joseph Tufo, Jr., Eglin AFB,

Florida, Court of Federal Claims

Number 98–0108V

14. Gerald M. Taylor on behalf of

Jennifer Sandoval, Ruskin, Florida,

Court of Federal Claims Number 98–

0113V

15. Erin and John Liable on behalf of

Sierra Liable, Salem, New Jersey,

Court of Federal Claims Number 98–

0120V

16. Bernard Bisson, Bradford, Vermont,

Court of Federal Claims Number 98–

0121V

17. Sheena Ackley on behalf of Tabitha

Ackley, Livingston, Texas, Court of

Federal Claims Number 98–0122V

18. Marano Maldonado Ramirez on

behalf of Maxi Maldonado Vasquez,

Corocal, Puerto Rico, Court of Federal

Claims Number 98–0133V

19. Blanca Buchno, Stockton, California,

Court of Federal Claims Number 98–

0134V

20. Robert D. Lovinger, M. D.,

Richmond, Virginia, Court of Federal

Claims Number 98–0138V

21. Margaret Nichols on behalf of

Elishama Nichols, Chicago, Illinois,

Court of Federal Claims Number 98–

0141V

22. Jason Ridgway on behalf Creighton

Ridgway, Round Rock, Texas, Court of

Federal Claims Number 98–0149V

23. Juli Levesque on behalf of Alex

Levesque, Pleasant Hill, California,

Court of Federal Claims Number 98–

0162V

24. Carrie Snyder on behalf of Kayla

Ann Snyder, Allentown,

Pennsylvania, Court of Federal Claims

Number 98–0163V

25. Francine and Emanuel Chaconis on

behalf of Alyssa Chaconis, Pamona,

New York, Court of Federal Claims

Number 98–0165V

26. Irma L. Lopez, Long Branch, New

Jersey, Court of Federal Claims

Number 98–0189V

27. Daisy Rivera Rodriguez, Ponce,

Puerto Rico, Court of Federal Claims

Number 98–0202V

28. Jill Boehler, Lincoln, Nebraska,

Court of Federal Claims Number 98–

0205V

29. Janice A. Trygg (Simonsen) and

Clifford G. Simonsen on behalf of

Harriet A. Simonsen, Deceased,

Portland, Oregon, Court of Federal

Claims Number 98–0206V

30. Madeleine and Marcelo Guilis on

behalf of Sage Guilis, Katonah, New

York, Court of Federal Claims Number

98–0305V

31. Elias Tebcherani on behalf of Lena

Marie Tebcherani, San Diego,

California, Court of Federal Claims

Number 98–0317V

Dated: June 19, 1998.

Claude Earl Fox,

Administrator.

[FR Doc. 98–17063 Filed 6–25–98; 8:45 am]

BILLING CODE 4160–15–U

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Cancer Institute; Notice of

Closed Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Cancer

Institute Initial Review Group, Subcommittee

A—Cancer Centers.

Date: August 6–7, 1998.

Time: August 6, 1998, 8:00 am to 6:00

pm—August 7, 1998, 8:00 am to 1:00 pm.

Agenda: To review and evaluate grant

applications.

Place: Bethesda Hyatt Regency, One

Bethesda Metro, Bethesda, MD 20814.

Contact Person: David E. Maslow, PhD,

Scientific Review Administrator, Grants

Review Branch, Division of Extramural

Activities, National Cancer Institute, National

Institutes of Health, 6130 Executive

Boulevard—EPN 643A, Rockville, MD

20892–7405, (301) 496–2330.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.393, Cancer Cause and

Prevention Research; 93.394, Cancer

Detection and Diagnosis Research; 93.395,

Cancer Treatment Research; 93.396, Cancer

Biology Research; 93.397, Cancer Centers

Support; 93.398, Cancer Research Manpower;

93.399, Cancer Control; 93.392, Cancer

Construction, National Institutes of Health,

HHS)

Dated: June 19, 1998.

LaVerne Y. Stringfield,

Committee Management Officer, NIH.

[FR Doc. 98–17003 Filed 6–25–98; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Cancer Institute; Notice of

Closed Meeting

Purusant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following meeting

of the National Cancer Institute Initial

Review Group:

Agenda/Purpose: To review, discuss and

evaluate grant applications.

Committee Name: Subcommittee H–

Clinical Trials.

Date: July 28–29, 1998.

Time: July 28–8:00 a.m. to recess; July 29–

8:00 a.m. to adjournment.

Place: Hyatt Regency—Bethesda, One

Bethesda Metro, Bethesda, MD 20814.

Contact Person: Deborah R. Jaffee, Ph.D.,

Scientific Review Administrator, National

Cancer Institute, NIH, 6130 Executive

Boulevard, North, Room 611C, Bethesda, MD

20892–7403, Telephone: 301/496–7721.

The meeting will be closed in accordance

with the provisions set forth in secs.

552b(c)(4) and 552b(c)(6), Title 5, U.S.C.

Applications and the discussions could

reveal confidential trade secrets or

commercial property such as patentable

material and personal information

concerning individuals associated with the

applications, the disclosure of which would

constitute a clearly unwarranted invasion of

personal privacy.

(Catalog of Federal Domestic Assistance

Program Numbers: 93.393, Cancer Cause and

Prevention Research; 93.394, Cancer

Detection and Diagnosis Research; 93.395,

Cancer Treatment Research; 93.396, Cancer

Biology Research; 93.397, Cancer Centers

Support; 93.398, Cancer Research Manpower;

93.399, Cancer Control)

Dated: June 19, 1998.

LaVerne Y. Stringfield,

Committee Management Officer, NIH.

[FR Doc. 98–17004 Filed 6–25–98; 8:45 am]

BILLING CODE 4140–01–M